Product Image

Curcumin Phytosome 1000 mg Citrus

Codeage Nanofood
4.7
★ ★ ★ ★ ★
(420 ratings)
Curcumin 1000 mg
Product Image
Score81
A substantial phytosome serving and low ongoing cost make this an appealing liquid curcumin option. Unclear active curcuminoid yield is the central limitation.
How scoring works
Quantity:2 Fluid Ounce(s) • (60 servings)
Goals:
Anti-Inflammatory Support
Joint Health
Anti-Aging
Brain Health
General Health
Heart Health

Score 81

A substantial phytosome serving and low ongoing cost make this an appealing liquid curcumin option. Unclear active curcuminoid yield is the central limitation.
How scoring works
$24.99($0.41 per serving)
BodyBuilding.com
$ 24.99
iHerb
$ 0.00
Pure Formulas
$ 24.99
Amazon
$ 24.99
Report prices

Analysis

A liquid serving supplies 1,000 mg of curcumin phytosome, pairing a large listed complex amount with phospholipid delivery. The format may appeal to people who dislike capsules and want a concentrated serving.

Goal alignment is strongest for inflammatory balance and joint comfort, while support for broad general health, brain health, or cardiovascular goals is narrower. Duplicate root-extract and phospholipid-complex descriptions do not clarify the actual curcuminoid yield.

Low serving cost gives the product strong value for an absorption-enhanced format. It suits buyers comfortable with a non-branded complex and liquid delivery, but potency-focused shoppers may want a stated active curcuminoid amount.

Who is it for
  • Adults who prefer liquid curcumin
  • People seeking joint-comfort or inflammatory-balance support
  • Value-focused users who want a phytosome format
Best for
  • High listed curcumin-complex intake
  • Inflammatory-balance and joint support
  • Capsule-free daily use

Pros

  • Provides 1,000 mg of curcumin phytosome
  • Phospholipid delivery may improve absorption
  • Strong value across 60 servings

Cons

  • Active curcuminoid yield is not disclosed
  • The phytosome is not identified as a branded delivery system
  • Complete excipient details are not supplied

Warnings

  • Curcumin may increase bleeding tendency with anticoagulant or antiplatelet medicines.
  • Curcumin may aggravate gallbladder symptoms or bile-flow obstruction.
  • The concentrated liquid may cause digestive upset in sensitive users, especially when taken without food.

Nutrient quality

87 Highest impact

Phospholipid complexing should improve absorption, though the non-branded delivery system is less characterized than patented forms. The complex amount is large, but duplicate extract and phospholipid entries leave active curcuminoid yield unclear.

Ingredient transparency

76 High impact

The phytosome amount is shown, but duplicate entries and missing active yield reduce clarity. Excipients and daily directions are absent from the supplied data, which leaves some label details uncertain.

Customer satisfaction

70 High impact

The aggregate satisfaction average is strong, though no detailed feedback is supplied. The substantial volume provides a useful aggregate satisfaction signal.

Value for money

93 Highest impact

A large enhanced-delivery complex at an accessible cost supports strong value. The serving cost is low for a phytosome-format curcumin product.

Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A+ Goal FitA+ Strength of SupportC CoverageA+ Formula Quality
Curcumin · 1000 mg

Curcumin directly targets several central inflammatory signaling pathways and is strongly aligned with the goal. The 1,000 mg phytosome complex combines a substantial amount with absorption-enhancing phospholipids.

A single-active design provides excellent depth, transparency, and coherence without padding. Bioavailable curcumin can increase bleeding tendency, so people using anticoagulant or antiplatelet medicines should seek clinical guidance before use.

Study evidence
Curcumin Supportive 68 studies
Joint Health
Impact
Highest effect
A Goal FitA- Strength of SupportC CoverageA Formula Quality
Curcumin · 1000 mg

Curcumin phytosome is directly aligned with joint comfort through inflammatory modulation and uses an absorption-enhancing phospholipid complex. Human evidence supports certain bioavailable curcumin preparations for comfort and mobility.

The one-gram amount appears substantial, but duplicate entries for root extract and phospholipid complex make the active curcuminoid yield unclear. Curcumin may increase bleeding tendency with anticoagulant or antiplatelet medicines.

Study evidence
Curcumin Supportive 62 studies
Anti-Aging
Impact
High effect
A- Goal FitC Strength of SupportC CoverageA+ Formula Quality
Curcumin · 1000 mg

Curcumin targets chronic inflammatory signaling and oxidative stress, both relevant to healthy aging. A phospholipid phytosome improves absorption compared with ordinary curcumin powder.

The complex weight is substantial and clearly stated, but the actual curcuminoid yield is missing. Dose adequacy and independent purity therefore cannot be verified despite the advanced delivery format.

Study evidence
Curcumin Supportive 6 studies
Brain Health
Impact
High effect
B- Goal FitB Strength of SupportD+ CoverageA Formula Quality

Curcumin may support brain resilience through antioxidant and inflammatory-balance pathways. Evidence is promising but less direct for cognitive performance than established nootropics or DHA.

The phytosome delivery should improve absorption, yet the 1,000 mg complex does not disclose actual curcuminoid yield. The focused formula provides neuroprotective support rather than memory, neurotransmitter, or brain-energy coverage.

Study evidence
Curcumin Supportive 32 studies
General Health
Impact
High effect
B+ Goal FitC Strength of SupportD+ CoverageA- Formula Quality
Curcumin · 1000 mg

Curcumin may support systemic inflammatory balance, which is relevant to general resilience but narrower than filling a core nutrient gap. The phytosome delivery system can improve absorption over plain curcumin.

The 1,000 mg complex amount is clear, yet the active curcuminoid yield is missing, so dose adequacy cannot be verified. Its focused phospholipid design is coherent and contains little obvious padding.

Study evidence
Curcumin Supportive 64 studies
Heart Health
Impact
High effect
C Goal FitB Strength of SupportD+ CoverageA Formula Quality
Curcumin · 1000 mg

Curcumin phytosome may support vascular health through anti-inflammatory and antioxidant pathways. It is less directly heart focused than established lipid, blood-pressure, or cardiac-energy ingredients.

The phytosome delivery may improve uptake, but the active curcuminoid yield is not stated. Curcumin may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Study evidence
Curcumin Supportive 70 studies

Ingredients

IngredientAmount per serving
Calories
5 Calorie(s)
Total Fat
0.3 Gram(s)
Total Carbohydrates
0.5 Gram(s)
Curcumin Phytosome (Curcuma longa Root Extract, Phospholipid Complex)
1000 mg
Adults 18–50
Report overview
C+ Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyA+ Value

The non-branded phytosome may improve absorption over a plain curcumin extract. A large complex amount is disclosed, but the active curcuminoid yield and independent testing status remain unclear. Its below-median serving cost gives it strong value for an advanced delivery format.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Curcumin on Postmenopausal Women's Health: A Systematic Review and Meta-Analysis.
    Jin D; Jin S; Sheng G; Cui Z; Gao P; Li G · Phytotherapy research : PTR · 2025
    Meta-analysis982 participants14 studies pooledGeneral Health forCurcumin
  2. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis.
    Sadeghi N; Mansoori A; Shayesteh A; Hashemi SJ · Phytotherapy research : PTR · 2020
    Randomized trial70 participantsGeneral Health forCurcumin
  3. Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial.
    Bommelaer G; Laharie D; Nancey S; Hebuterne X; Roblin X; Nachury M; Peyrin-Biroulet L; Fumery M; Richard D; Pereira B; Goutte M; Buisson A; POPCUR study group · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021
    Randomized trial62 participantsGeneral Health forCurcumin
  4. Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study.
    Cox KHM; White DJ; Pipingas A; Poorun K; Scholey A · Nutrients · 2021
    Randomized trial80 participantsBrain Health Anti-Aging forCurcumin
  5. Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: a systematic review and dose-response meta-analysis of randomized controlled trials.
    Sarraf P; Parohan M; Javanbakht MH; Ranji-Burachaloo S; Djalali M · Nutrition research (New York, N.Y.) · 2020
    Meta-analysis139 participants4 studies pooledBrain Health forCurcumin
  6. The Effect of Curcumin Differs on Individual Cognitive Domains across Different Patient Populations: A Systematic Review and Meta-Analysis.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Pharmaceuticals (Basel, Switzerland) · 2024
    Meta-analysis389 participants8 studies pooledBrain Health forCurcumin
  7. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study.
    Ringman JM; Frautschy SA; Teng E; Begum AN; Bardens J; Beigi M; Gylys KH; Badmaev V; Heath DD; Apostolova LG; Porter V; Vanek Z; Marshall GA; Hellemann G; Sugar C; Masterman DL; Montine TJ; Cummings JL; Cole GM · Alzheimer's research & therapy · 2014
    Randomized trial36 participantsBrain Health forCurcumin
  8. Effects of nanocurcumin supplementation on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Wilar G; Suhandi C; Fukunaga K; Shigeno M; Kawahata I; Abdulah R; Sasaki T · Pharmacological research · 2025
    Meta-analysis1,394 participants20 studies pooledCardiovascular Support forCurcumin
  9. The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Alidadi M; Sahebkar A; Eslami S; Vakilian F; Jarahi L; Alinezhad-Namaghi M; Arabi SM; Vakili S; Tohidinezhad F; Nikooiyan Y; Norouzy A · Advances in experimental medicine and biology · 2021
    Randomized trial66 participantsCardiovascular Support Heart Health forCurcumin
  10. Effects of curcumin on blood pressure: A systematic review and dose-response meta-analysis.
    Karimi A; Moini Jazani A; Darzi M; Doost Azgomi RN; Vajdi M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2026
    Meta-analysis1,377 participants17 studies pooledCardiovascular Support forCurcumin
  11. A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels.
    Sahebkar A · Clinical nutrition (Edinburgh, Scotland) · 2014
    Meta-analysis223 participants5 studies pooledCardiovascular Support forCurcumin
  12. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis.
    Zeng L; Yu G; Hao W; Yang K; Chen H · Bioscience reports · 2022
    Meta-analysis1,621 participants15 studies pooledJoint Health forCurcumin
  13. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.
    Zhao J; Liang G; Zhou G; Hong K; Yang W; Liu J; Zeng L · Journal of ethnopharmacology · 2024
    Meta-analysis2,175 participants23 studies pooledJoint Health forCurcumin
  14. The Oral Administration of Highly-Bioavailable Curcumin for One Year Has Clinical and Chondro-Protective Effects: A Randomized, Double-Blinded, Placebo-Controlled Prospective Study.
    Nakagawa Y; Mori K; Yamada S; Mukai S; Hirose A; Nakamura R · Arthroscopy, sports medicine, and rehabilitation · 2022
    Randomized trial50 participantsJoint Health forCurcumin
  15. Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial.
    Rahimnia AR; Panahi Y; Alishiri G; Sharafi M; Sahebkar A · Drug research · 2016
    Randomized trial40 participantsJoint Health forCurcumin
  16. Effect of curcumin on C-reactive protein as a biomarker of systemic inflammation: An updated meta-analysis of randomized controlled trials.
    Gorabi AM; Abbasifard M; Imani D; Aslani S; Razi B; Alizadeh S; Bagheri-Hosseinabadi Z; Sathyapalan T; Sahebkar A · Phytotherapy research : PTR · 2022
    Meta-analysis32 studies pooledAnti-Inflammatory Support forCurcumin
  17. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.
    Sahebkar A · Phytotherapy research : PTR · 2014
    Meta-analysis342 participants6 studies pooledAnti-Inflammatory Support forCurcumin
  18. Anti-Inflammatory Efficacy of Curcumin as an Adjunct to Non-Surgical Periodontal Treatment: A Systematic Review and Meta-Analysis.
    Zhang Y; Huang L; Zhang J; De Souza Rastelli AN; Yang J; Deng D · Frontiers in pharmacology · 2024
    Meta-analysis846 participants18 studies pooledAnti-Inflammatory Support forCurcumin
  19. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials.
    Derosa G; Maffioli P; Simental-Mendía LE; Bo S; Sahebkar A · Pharmacological research · 2018
    Meta-analysis9 studies pooledAnti-Inflammatory Support forCurcumin
  20. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials.
    White CM; Pasupuleti V; Roman YM; Li Y; Hernandez AV · Pharmacological research · 2020
    Meta-analysis1,344 participants19 studies pooledAnti-Inflammatory Support forCurcumin
  21. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women.
    Akazawa N; Choi Y; Miyaki A; Tanabe Y; Sugawara J; Ajisaka R; Maeda S · Nutrition research (New York, N.Y.) · 2013
    Clinical trial32 participantsAnti-Aging forCurcumin
  22. A novel phospholipid delivery system of curcumin (Meriva®) preserves muscular mass in healthy aging subjects.
    Franceschi F; Feregalli B; Togni S; Cornelli U; Giacomelli L; Eggenhoffner R; Belcaro G · European review for medical and pharmacological sciences · 2016
    Non-randomized trial86 participantsAnti-Aging forCurcumin
  23. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.
    Nunes YC; Mendes NM; Pereira de Lima E; Chehadi AC; Lamas CB; Haber JFS; Dos Santos Bueno M; Araújo AC; Catharin VCS; Detregiachi CRP; Laurindo LF; Tanaka M; Barbalho SM; Marin MJS · Nutrients · 2024
    Systematic review15 studies pooledAnti-Aging forCurcumin
  24. Curcumin and arterial function in health and disease: impact on oxidative stress and inflammation.
    Fleenor BS; Carlini NA; Campbell MS · Current opinion in clinical nutrition and metabolic care · 2020
    Narrative reviewAnti-Aging forCurcumin
  25. Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis.
    Zhang F; Niu B · Medicine · 2025
    Meta-analysis7 studies pooledAnti-Inflammatory Support forCurcumin
  26. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ · Nutrition & metabolism · 2024
    Randomized trial84 participantsAnti-Inflammatory Support Cardiovascular Support Detoxification forCurcumin
  27. Is Curcumin Intake Really Effective for Chronic Inflammatory Metabolic Disease? A Review of Meta-Analyses of Randomized Controlled Trials.
    Lee YM; Kim Y · Nutrients · 2024
    Systematic review54 studies pooledAnti-Inflammatory Support forCurcumin
  28. [Curcumin in children with autism spectrum disorder: systemic inflammation, sensory regulation, and gut-brain interaction disorders. A randomized, double-blind, placebo-controlled clinical trial (CURATEA)].
    Vergara Serpa JJ; Sumalla Cano S · Nutricion hospitalaria · 2026
    Randomized trial60 participantsBrain Health forCurcumin
  29. Curcumin-Rich Curry Consumption Is Associated with Lower Risk of Cognitive Decline and Incidence of Mild Cognitive Impairment or Dementia: An Asian Population-Based Study.
    Lu Y; Lee TS; Lim WS; Yap P; Cheong CY; Rawtaer I; Liew TM; Gwee X; Gao Q; Yap KB; Ng TP · Nutrients · 2025
    Cohort study2,920 participantsBrain Health forCurcumin
  30. Curcumin-Rich Curry Consumption and Neurocognitive Function from 4.5-Year Follow-Up of Community-Dwelling Older Adults (Singapore Longitudinal Ageing Study).
    Ng TP; Nyunt MSZ; Gao Q; Gwee X; Chua DQL; Yap KB · Nutrients · 2022
    Cohort study2,734 participantsBrain Health forCurcumin
  31. The effects of oral administration of curcumin-galactomannan complex on brain waves are consistent with brain penetration: a randomized, double-blinded, placebo-controlled pilot study.
    Khanna A; Das S S; Kannan R; Swick AG; Matthewman C; Maliakel B; Ittiyavirah SP; Krishnakumar IM · Nutritional neuroscience · 2022
    Randomized trial18 participantsBrain Health forCurcumin
  32. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials.
    Qin S; Huang L; Gong J; Shen S; Huang J; Ren H; Hu H · Nutrition journal · 2018
    Meta-analysis649 participants7 studies pooledCardiovascular Support forCurcumin
  33. The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Metaanalysis of Randomized Controlled Trials.
    Tabrizi R; Vakili S; Lankarani KB; Akbari M; Mirhosseini N; Ghayour-Mobarhan M; Ferns G; Karamali F; Karamali M; Taghizadeh M; Kouchaki E; Asemi Z · Current pharmaceutical design · 2019
    Meta-analysis1,890 participants26 studies pooledCardiovascular Support forCurcumin
  34. Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial.
    Helli B; Gerami H; Kavianpour M; Heybar H; Hosseini SK; Haghighian HK · Endocrine, metabolic & immune disorders drug targets · 2022
    Randomized trial90 participantsCardiovascular Support Heart Health forCurcumin
  35. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Vajdi M; Hassanizadeh S; Hassanizadeh R; Bagherniya M · Nutrition reviews · 2024
    Meta-analysis905 participants15 studies pooledDetoxification forCurcumin
  36. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Ebrahimzadeh A; Fooladshekan S; Mohseni S; Mohtashamian A; Babajafari S; Sohrabi Z · Food science & nutrition · 2025
    Meta-analysis14 studies pooledDetoxification forCurcumin
  37. Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Yaikwawong M; Kamdee K; Chuengsamarn S · International journal of molecular sciences · 2025
    Randomized trial227 participantsDetoxification forCurcumin
  38. A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study.
    T Krishnareddy N; Thomas JV; Nair SS; N Mulakal J; Maliakel BP; Krishnakumar IM · BioMed research international · 2019
    Randomized trial48 participantsDetoxification forCurcumin
  39. The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial.
    Parohan M; Sarraf P; Javanbakht MH; Foroushani AR; Ranji-Burachaloo S; Djalali M · Nutritional neuroscience · 2021
    Randomized trial100 participantsGeneral Health forCurcumin
  40. Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Thanawala S; Shah R; Alluri KV; Bhupathiraju K; Prasad N; Agarwal Y · Journal of pain research · 2025
    Randomized trial139 participantsGeneral Health forCurcumin
  41. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials.
    Onakpoya IJ; Spencer EA; Perera R; Heneghan CJ · International journal of rheumatic diseases · 2018
    Meta-analysis797 participants7 studies pooledGeneral Health forCurcumin
  42. Effectiveness and safety of turmeric for the treatment of COVID-19: An updated systematic review and meta-analysis of randomized controlled trials.
    Sawangjit R; Sadoyu S; Manosanthipaibul S; Teerawattanapong N; Puttarak P; Wanaratna K; Charoensup R; Hiransai P; Meetam T; Chaiyakunapruk N · Complementary therapies in medicine · 2025
    Meta-analysis1,407 participants23 studies pooledGeneral Health forCurcumin
  43. The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial.
    Shafabakhsh R; Asemi Z; Reiner Z; Soleimani A; Aghadavod E; Bahmani F · Iranian journal of kidney diseases · 2021
    Randomized trial60 participantsHeart Health forCurcumin
  44. Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk.
    El-Rakabawy OM; Elkholy AA; Mahfouz AA; Abdelsalam MM; El Wakeel LM · Scientific reports · 2025
    Randomized trial72 participantsHeart Health forCurcumin
  45. The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    Yaikwawong M; Jansarikit L; Jirawatnotai S; Chuengsamarn S · Nutrients · 2024
    Randomized trial227 participantsHeart Health forCurcumin
  46. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
    Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H · Frontiers in immunology · 2022
    Meta-analysis2,396 participants29 studies pooledJoint Health forCurcumin
  47. The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.
    Bideshki MV; Jourabchi-Ghadim N; Radkhah N; Behzadi M; Asemani S; Jamilian P; Zarezadeh M · Phytotherapy research : PTR · 2024
    Meta-analysis11 studies pooledJoint Health forCurcumin
  48. The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis.
    Hsiao AF; Lien YC; Tzeng IS; Liu CT; Chou SH; Horng YS · Complementary therapies in medicine · 2021
    Meta-analysis1,258 participants11 studies pooledJoint Health forCurcumin